Literature DB >> 26448469

Residual Neuromuscular Block in the Elderly: Incidence and Clinical Implications.

Glenn S Murphy1, Joseph W Szokol, Michael J Avram, Steven B Greenberg, Torin D Shear, Jeffery S Vender, Kruti N Parikh, Shivani S Patel, Aashka Patel.   

Abstract

BACKGROUND: Elderly patients are at increased risk for anesthesia-related complications. Postoperative residual neuromuscular block (PRNB) in the elderly, defined as a train-of-four ratio less than 0.9, may exacerbate preexisting muscle weakness and respiratory dysfunction. In this investigation, the incidence of PRNB and associated adverse events were assessed in an elderly (70 to 90 yr) and younger cohort (18 to 50 yr).
METHODS: Data were prospectively collected on 150 younger and 150 elderly patients. Train-of-four ratios were measured on arrival to the postanesthesia care unit (PACU). After tracheal extubation, patients were examined for adverse respiratory events during transport to the PACU, for 30 min after PACU admission, and during hospital admission. Postoperative muscle weakness was quantified using a standardized examination, and PACU and hospital lengths of stay were determined.
RESULTS: The incidence of PRNB was 57.7% in elderly and 30.0% in younger patients (difference, -27.7%; 99% CI, -41.2 to -13.1%; P < 0.001). Airway obstruction, hypoxemic events, signs and symptoms of muscle weakness, postoperative pulmonary complications, and increased PACU and hospital lengths of stay were observed more frequently in the elderly (all P < 0.01). Within each cohort, most adverse events were observed in patients with PRNB. Younger patients with PRNB received larger total doses of rocuronium than did those without it (60 vs. 50 mg, P < 0.01), but there were no differences in rocuronium dose between elderly patients with PRNB and those without it (both 50 mg).
CONCLUSION: The elderly are at increased risk for PRNB and associated adverse outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 26448469     DOI: 10.1097/ALN.0000000000000865

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  26 in total

1.  Neuromuscular Block and Blocking Agents in 2018.

Authors:  Christoph Unterbuchner
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-04-01

Review 2.  Practical Management of Anaesthesia in the Elderly.

Authors:  Camilla Strøm; Lars Simon Rasmussen; Jacob Steinmetz
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

3.  Survey of neuromuscular monitoring and assessment of postoperative residual neuromuscular block in a postoperative anaesthetic care unit.

Authors:  Xu Feng Lin; Christine Yoke Kuen Yong; May Un Sam Mok; Poopalalingam Ruban; Patrick Wong
Journal:  Singapore Med J       Date:  2019-09-19       Impact factor: 1.858

4.  Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.

Authors:  Brandon M Togioka; Katie J Schenning
Journal:  Drugs Aging       Date:  2022-08-08       Impact factor: 4.271

Review 5.  [Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks].

Authors:  C Unterbuchner; K Ehehalt; B Graf
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

6.  Concomitant Sacral Neuromodulation and Gynecologic Surgery: A Single-Institution Experience.

Authors:  Neha T Sudol; Taylor J Brueseke; Alyssa Lo; Karen L Noblett
Journal:  Neuromodulation       Date:  2019-12-15

7.  Effects of neuromuscular blocking agents on the clinical performance of i-gel® and surgical condition in elderly patients undergoing hand surgery: a prospective randomized controlled trial.

Authors:  Choon-Kyu Cho; Minhye Change; Seok-Jin Lee; Tae-Yun Sung
Journal:  Int J Med Sci       Date:  2021-04-16       Impact factor: 3.738

8.  Automated Quantitative Relaxometry for Deep Neuromuscular Blockade in Robot-Assisted Prostatectomy.

Authors:  Michèle Sunnen; Martin Schläpfer; Peter Biro
Journal:  Rom J Anaesth Intensive Care       Date:  2020-08-10

9.  Vigilance: the behavioral impact of quantitative monitoring on administration and antagonism of neuromuscular blocking agents.

Authors:  Anastasia D Grivoyannis; Virginia Tangel; Cynthia A Lien
Journal:  J Clin Monit Comput       Date:  2021-06-22       Impact factor: 1.977

Review 10.  Neuromuscular blockade in the elderly patient.

Authors:  Luis A Lee; Vassilis Athanassoglou; Jaideep J Pandit
Journal:  J Pain Res       Date:  2016-06-17       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.